Needham & Company LLC Reiterates Buy Rating for LivaNova (NASDAQ:LIVN)

Needham & Company LLC restated their buy rating on shares of LivaNova (NASDAQ:LIVN – Free Report) in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has a $72.00 target price on the stock. Several other equities analysts also recently issued reports on the stock. Barclays lifted their price target on shares […]

Related Keywords

Robertw Baird , ,Ameriprise Financial Inc ,Dimensional Fund Advisors ,Barclays ,Greenlight Capital Inc ,Needham Company ,Primecap Management Co ,Vanguard Group Inc ,Free Report ,Moderate Buy ,Get Free Report ,Fund Advisors ,Ameriprise Financial ,Advanced Circulatory Support ,Livanova Daily ,Livanova ,Nasdaq Livn ,Livn ,Medical ,Reiterated Rating ,Needham Company Llc ,